NCT01136824已完成不适用
Chemotherapy-induced Symptoms in Sarcoma Patients and the Impact of Tumor Burden
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 11
- 试验地点
- 1
- 主要终点
- To determine the extent of symptom burden and quality of life in sarcoma patients receiving AI chemotherapy.
研究概览
简要总结
Assessments (survey data) in this study are designed to sample the symptom burden of patients undergoing adjuvant and neoadjuvant chemotherapy in the hospital. There will be no change in the treatment plan for these patients.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who are receiving doxorubicin plus ifosfamide (AI)
排除标准
- •There is no exclusion criteria
结局指标
主要结局
To determine the extent of symptom burden and quality of life in sarcoma patients receiving AI chemotherapy.
时间窗: 2 years
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
终止
不适用
Symptom Burden in Patients With Cancer- and Treatment-Related Skin ProblemsSkin CancerNCT01193036M.D. Anderson Cancer Center11
终止
不适用
Chart Review of Treatments Received by Patients Diagnosed With Soft Tissue SarcomaSarcomaNCT00322855New Mexico Cancer Care Alliance1
已完成
不适用
eSMART Trial to Evaluate ASyMSCancerNCT02356081Louise McKean829
招募中
不适用
Patient-reported symptom burden under chemotherapy with fluorouracilColorectal cancerDRKS00022869Pharmazeutisches Institut50
已完成
不适用
Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic CancerPancreatic CancerNCT00805688M.D. Anderson Cancer Center100